XBIUSDT Price Today: Live Biotech Data

XBIUSDT is trading at $[LIVE PRICE] ([+/-X%] in the past 24 hours), with the biotech sector responding to current market conditions across derivatives exchanges. This page tracks the live XBIUSDT current price, the technical setup on the chart, and the biotech catalysts driving XBI movement today. This content is for informational purposes only and does not constitute investment advice.

Live XBIUSDT Market Data | Last Updated: [DATE] [TIME] UTC

Open interest is the total number of outstanding XBIUSDT perpetual contracts not yet settled. Rising open interest alongside rising price suggests new money entering bullish positions; rising open interest with falling price indicates growing short conviction. Trading volume represents the total XBIUSDT contracts traded in the last 24 hours. Elevated volume during a price move confirms conviction, while price moves on low volume may indicate weak follow-through.

XBIUSDT Price Chart

The XBIUSDT price chart shows [bullish/bearish/sideways] structure on the daily timeframe, with price [above/below/testing] the [key level] zone as of [DATE/TIME]. The most recent session produced [descriptive observation of recent candle structure], with volume [confirming/not confirming] the directional move. Full technical level analysis appears in the Technical Analysis section below.

[TradingView interactive chart embed: BYBIT:XBIUSDT, candlestick default, timeframes: 1D / 1W / 1M / 3M / 1Y]

What Is XBIUSDT?

XBIUSDT is a perpetual futures contract available on cryptocurrency derivatives exchanges, primarily Bybit, that tracks the price of XBI (the SPDR S&P Biotech ETF) quoted in USDT. Traders use XBIUSDT to gain exposure to U.S. biotech sector performance within the crypto ecosystem without needing to hold actual ETF shares. In the crypto markets, XBI refers to this same NYSE Arca-traded biotech ETF, now accessible as a crypto perpetual futures contract on Bybit. For a full breakdown of the underlying asset and contract mechanics, see What Is XBIUSDT? SPDR S&P Biotech ETF Explained.

The quote currency, USDT (Tether), is a fiat-collateralized stablecoin pegged 1:1 to the US dollar, issued by Tether Limited. Because USDT maintains dollar parity under normal market conditions, XBIUSDT prices are effectively USD-equivalent values. A XBIUSDT price of $85.00 means one unit of XBI exposure costs approximately $85.00 in USD terms.

XBIUSDT Ticker Breakdown

Where Is XBIUSDT Traded?

XBIUSDT is listed as a USDT perpetual contract on Bybit as the primary venue, with MEXC available as a secondary exchange. As of this writing, XBIUSDT is not listed on Binance. Traders searching for the pair on Bybit can navigate to the Derivatives section, select USDT Perpetual, and search "XBI" to locate the contract. See the XBIUSDT perpetual contract listing announcement for full contract specifications.

What Is XBI? The Underlying ETF Explained

XBI is the NYSE Arca ticker for the SPDR S&P Biotech ETF, an exchange-traded fund managed by State Street Global Advisors (SSGA) that tracks the S&P Biotechnology Select Industry Index. SSGA, the asset management division of State Street Corporation and the creator of the first U.S. ETF (SPY), manages XBI's index replication, portfolio rebalancing, and fund administration. XBI is the underlying asset of the XBIUSDT perpetual futures contract available on Bybit. When XBI moves on NYSE Arca, XBIUSDT follows through the index price feed mechanism.

XBI ETF Overview

The S&P Biotechnology Select Industry Index, which XBI replicates, uses an equal-weight methodology. Each constituent receives approximately the same portfolio allocation regardless of market capitalization, meaning a small-cap biotech with a $500M market cap has roughly the same influence on XBI's performance as a $20B large-cap name. This equal-weight construction gives XBI meaningful exposure to small- and mid-cap biotech companies, including clinical-stage firms with binary catalyst risk, which makes XBI (and by extension XBIUSDT) more volatile than large-cap-dominated biotech benchmarks. XBI rebalances quarterly back to equal weights, creating a mechanical sell-winner, buy-loser dynamic that distinguishes its behavior from cap-weighted peers.

XBI ETF Fundamentals | Data verified from the SSGA SPDR S&P Biotech ETF fund page. Source: SSGA.com

XBI Top Holdings

XBI holds approximately 130+ biotechnology companies with equal weighting, so no single position dominates the fund. Holdings rotate quarterly as SSGA rebalances to equal weights.

XBI Top Holdings | Data as of [DATE]. Source: SSGA.com. Verify current weights before use.

Holdings and weights change quarterly with rebalancing. Pull current data from SSGA.com before each publication cycle. Do not publish with placeholder names.

XBI vs. IBB: Key Differences

XBI and IBB both track the U.S. biotechnology sector, but their index construction produces meaningfully different performance characteristics and risk profiles. IBB is the iShares Biotechnology ETF, managed by BlackRock, listed on NASDAQ. IBB tracks the NASDAQ Biotechnology Index (NBI), a cap-weighted index that includes both biotechnology and pharmaceutical companies, a broader and differently weighted universe than the S&P Biotechnology Select Industry Index tracked by XBI.

The practical consequence is significant: XBI's equal-weight structure gives small- and mid-cap biotech stocks full index representation, while IBB's cap-weighting means large-cap names like Amgen, Gilead Sciences, and Biogen absorb a disproportionate share of the index. XBI has historically produced stronger returns than IBB during small-cap biotech bull markets, while IBB has historically outperformed when large-cap leaders drive sector gains. Only XBI has a crypto-listed perpetual futures contract (XBIUSDT).

How XBIUSDT Works: Perpetual Futures Mechanics

A perpetual futures contract is a derivative instrument with no expiry date, allowing traders to hold a position indefinitely without rolling into a new contract. Unlike CME-listed futures contracts for traditional assets, which settle on a fixed date, crypto perpetuals remain open as long as the trader maintains sufficient margin. XBIUSDT is an example of this structure, giving traders continuous exposure to XBI ETF price movement without needing to hold ETF shares or manage contract rollovers.

What Is a Perpetual Futures Contract?

Perpetual futures differ from traditional dated futures in three structural ways:

1. No expiry date. Positions remain open indefinitely, subject only to margin maintenance.
2. USDT settlement. All position settlements are denominated in USDT. No XBI shares change hands.
3. Funding rate mechanism. A periodic payment between long and short holders keeps the perpetual price tethered to the underlying asset price.

Traders can access leveraged exposure to XBI price movement through XBIUSDT, amplifying both potential gains and potential losses. Traders using leverage on XBIUSDT risk liquidation (the forced closure of a leveraged position by the exchange when margin falls below the maintenance threshold) if price moves against them beyond their margin buffer. For a step-by-step walkthrough of opening and managing positions, see the XBIUSDT trading guide.

How Does XBIUSDT Track the XBI ETF Price?

XBIUSDT closely tracks XBI but is not always identical to the ETF's NYSE Arca price. The tracking mechanism works through three sequential steps:

1. Index price feed. Bybit calculates a reference index price using real-time XBI ETF market data from NYSE Arca. This index price represents the fair value of the underlying asset at any moment.
2. Mark price anchoring. The mark price (the manipulation-resistant reference price used for unrealized PnL and liquidation calculations, distinct from the last traded price) is derived from the index price plus a moving average of the funding rate basis. The exchange uses mark price rather than last traded price to prevent temporary manipulation from triggering mass liquidations.
3. Funding rate correction. When XBIUSDT trades at a premium to the index, positive funding rates cause longs to pay shorts, pulling the perpetual price back toward the index. When XBIUSDT trades at a discount, negative funding rates cause shorts to pay longs, pushing price back up.

Small deviations between XBIUSDT and the XBI ETF price do occur, particularly during after-hours periods when NYSE Arca is closed but XBIUSDT continues trading 24/7. FDA announcements or other biotech events outside U.S. market hours can create gap discrepancies that resolve when NYSE Arca reopens.

XBIUSDT Funding Rate Explained

The funding rate (the periodic payment exchanged between long and short position holders on Bybit every 8 hours) keeps the XBIUSDT perpetual price anchored near the underlying XBI ETF price. The current XBIUSDT funding rate is visible in the metrics dashboard at the top of this page.

A positive funding rate means long positions pay short positions; the market is net long, reflecting bullish sentiment. A negative funding rate means short positions pay long positions; the market is net short, reflecting bearish sentiment. The magnitude matters: a rate of +0.01% is neutral background noise, while a rate of +0.05% or higher indicates a crowded long trade where elevated funding costs create pressure for longs to reduce exposure. Holding a long XBIUSDT position through three 8-hour funding cycles at +0.05% per cycle costs 0.15% of notional position size in funding fees, independent of price movement. Traders monitoring open interest in perpetual futures contracts alongside funding rate direction gain a cleaner picture of market positioning.

What Moves XBIUSDT Price: Biotech Catalysts & Market Drivers

XBIUSDT price moves when its underlying asset, XBI (SPDR S&P Biotech ETF), moves. XBI responds most sharply to five categories of driver. Understanding these drivers translates directly into reading XBIUSDT price action with context that no price aggregator or exchange interface currently provides.

FDA Regulatory Catalysts

The FDA (U.S. Food and Drug Administration) is the primary regulatory catalyst for XBI price movement, with drug approval decisions capable of historically moving individual biotech stocks 50% to over 200% in a single session. When a major XBI holding receives FDA approval for a new drug, its stock price can surge and lift XBI and XBIUSDT. A rejection or a Complete Response Letter (CRL, which requests more data and effectively delays or denies approval) can send the same stock down 40% to 80% in a day.

The most predictable FDA events are Prescription Drug User Fee Act (PDUFA) dates. A PDUFA date is the deadline by which the FDA must complete its review of a New Drug Application (NDA) or Biologics License Application (BLA). Traders monitor upcoming PDUFA dates because they represent scheduled binary events: known dates on the calendar where the probability of a sharp XBI move is elevated. Clusters of PDUFA dates across multiple XBI holdings in the same week can create broad sector volatility that moves XBIUSDT beyond what any single stock approval would generate.

Clinical Trial Readouts

Phase 2 and Phase 3 clinical trial data readouts are the second major catalyst category for XBI and XBIUSDT. When a major XBI holding reports positive Phase 3 trial results, it creates immediate upward pressure on the ETF; negative or disappointing results produce the reverse. Interim analyses from ongoing trials can trigger moves comparable in size to PDUFA date outcomes.

Macro Factors: Rates, Risk-On/Risk-Off

Biotech is a growth and innovation sector with high sensitivity to interest rate expectations. Rising rate environments compress valuations of speculative, revenue-light biotech names that make up a significant portion of XBI, because higher discount rates reduce the present value of future pipeline revenues. Broad market risk-off episodes, driven by Federal Reserve policy shifts, geopolitical events, or credit stress, typically pressure XBI and XBIUSDT alongside other high-beta growth assets. Risk-on periods, characterized by falling rate expectations or strong risk appetite, provide a favorable environment for XBI's small-cap-heavy composition.

Broad Market and Individual Stock Events

S&P 500 and NASDAQ directional moves create sympathy pressure on XBI through general risk-on/risk-off sentiment shifts. Individual earnings reports, mergers and acquisitions announcements, and partnership deals involving large XBI holdings also produce directional pressure on the ETF and therefore on XBIUSDT.

Today's XBI vs. XBIUSDT Price Comparison | Updated: [DATE] [TIME] UTC

XBI (SPDR S&P Biotech ETF) most recently closed at $[XX.XX] on NYSE Arca. XBIUSDT on Bybit is currently trading at $[XX.XX], representing a [premium/discount/near-parity] of approximately [X]% to the ETF's last closing price. XBIUSDT trades 24 hours a day, seven days a week, while XBI trades only during NYSE Arca market hours (9:30 a.m. to 4:00 p.m. ET on trading days). Price discrepancies typically narrow once NYSE Arca reopens, corrected by the funding rate mechanism described above.

Upcoming Biotech Catalyst Calendar | Data as of [DATE]. Sources: FDA advisory committee calendar, BioPharma Catalyst. Update on every page refresh.

Catalyst outcomes are unknown in advance. FDA decisions and clinical trial results can move XBI and XBIUSDT sharply in either direction.

XBIUSDT Technical Analysis

XBIUSDT is currently trading in a [bullish/bearish/sideways] trend, with price [above/below] its 50-period and 200-period exponential moving averages (EMAs) as of [DATE/TIME]. This analysis reflects chart data from the Bybit XBIUSDT daily timeframe and should be reverified against the live chart before any trading decision.

Current Trend Assessment

Price sits [above/below] the 50-period EMA at approximately $[XX.XX] and [above/below] the 200-period EMA at approximately $[XX.XX]. The 50 EMA [has/has not] crossed above or below the 200 EMA in recent sessions. [A Golden Cross (50 EMA above 200 EMA, historically a bullish alignment) / A Death Cross (50 EMA below 200 EMA, historically a bearish alignment) / No crossover event is currently present on the daily chart.] Price relative to both moving averages establishes the directional bias: trading above both levels suggests the path of least resistance is upward; trading below both levels suggests the opposite.

Key Support and Resistance Levels

Support is the price zone where buying interest has historically emerged and sellers have been absorbed. Resistance is the zone where selling pressure has historically emerged and buying has stalled. The levels below are derived from the daily XBIUSDT chart and reflect areas of prior price reaction. All levels are approximate and should be verified on the live chart.

Technical analysis as of [DATE/TIME] UTC

A break below primary support opens a path toward secondary support. A confirmed close above primary resistance shifts focus to secondary resistance as the next technical reference level.

RSI and Moving Average Signals

The RSI (Relative Strength Index, a momentum oscillator ranging from 0 to 100 where readings above 70 suggest overbought conditions and readings below 30 suggest oversold conditions) currently reads [XX] on the daily XBIUSDT chart. An RSI of [XX] is [in neutral territory / approaching overbought territory and may suggest momentum exhaustion where a pause or pullback becomes more probable / in oversold territory where selling pressure has historically begun to abate]. Volume on the most recent session was [above/below] the 20-period average, [confirming/not confirming] conviction behind the current directional move.

XBIUSDT Price Outlook: Technical Scenarios

The bullish scenario for XBIUSDT requires price to hold above $[XX.XX] support on a daily close, with the next technical reference level near $[XX.XX] where prior sellers previously absorbed buying pressure. This scenario becomes more probable if the broader biotech sector receives positive catalyst news (an FDA approval or strong clinical readout from a major XBI holding) or if macro conditions shift toward a risk-on environment with declining rate expectations. For a longer-term view with bull, base, and bear price targets, see the XBIUSDT forecast 2026.

The bearish scenario materializes on a sustained close below $[XX.XX] support, which has historically preceded a test of the $[XX.XX] zone where prior buyers emerged in [TIMEFRAME]. Elevated XBIUSDT funding rates alongside declining open interest could signal long position unwinding that accelerates downside pressure. A negative FDA outcome (Complete Response Letter or rejection) for a major XBI holding on an upcoming PDUFA date represents a discrete downside risk to the ETF and therefore to XBIUSDT regardless of the prevailing technical trend.

This analysis is for informational purposes only and does not constitute investment advice. Trading perpetual futures involves significant risk. These are technical reference levels based on observable chart structure, not price targets or trading recommendations.

How to Trade XBIUSDT

XBIUSDT is accessible as a USDT perpetual contract on Bybit (primary venue) and MEXC (secondary venue). Both platforms require a funded crypto exchange account to access the derivatives section.

1. Create and verify your account. Open an account on Bybit and complete the identity verification (KYC) process required by the exchange.
2. Fund your account with USDT. XBIUSDT is a USDT-margined contract. Deposit USDT directly or convert another asset to USDT within the exchange, as all margin and settlement occur in USDT.
3. Navigate to the USDT Perpetual section. On Bybit, select Derivatives from the top navigation, then choose USDT Perpetual. Search "XBI" in the search bar to locate the XBIUSDT contract.
4. Set your leverage and position size. Select your desired leverage level before placing an order. Lower leverage reduces liquidation risk; higher leverage amplifies both gains and losses. XBIUSDT is a niche pair with lower liquidity than major crypto perpetuals, which can produce wider spreads and potential price slippage on large orders.
5. Understand your liquidation risk before entering. Traders using leverage risk liquidation (the forced closure of a leveraged position by the exchange when margin falls below the maintenance threshold) if price moves against their position. Set a stop-loss order and size positions consistent with your margin capacity.

For full step-by-step instructions including margin mode, order types, and stop-loss setup, see the complete XBIUSDT trading guide.

This section describes how the instrument works. Nothing here constitutes a recommendation to trade XBIUSDT or any other instrument.

XBIUSDT FAQ: Frequently Asked Questions

What is XBIUSDT?

XBIUSDT is a perpetual futures contract listed on Bybit that tracks the price of XBI (the SPDR S&P Biotech ETF), quoted in USDT (Tether, a USD-pegged stablecoin). Traders use it to gain exposure to U.S. biotech sector price movement within the crypto ecosystem, without holding actual ETF shares. It is not a token, coin, or spot instrument; it is a derivative contract settled in USDT.

What is the XBI ETF?

The SPDR S&P Biotech ETF (XBI), managed by State Street Global Advisors (SSGA), tracks the S&P Biotechnology Select Industry Index using an equal-weight methodology. XBI holds approximately 130+ U.S. biotechnology companies, rebalances quarterly, and trades on NYSE Arca. XBI is the underlying asset that XBIUSDT perpetual futures are priced against on Bybit.

How does XBIUSDT track the XBI ETF price?

Through an index price feed, XBIUSDT tracks XBI: Bybit calculates a reference index price from real-time XBI ETF market data, then applies the funding rate mechanism to keep the perpetual contract price near that index level. When XBIUSDT trades at a premium to the index, positive funding rates cause longs to pay shorts, pulling the price down. When it trades at a discount, negative rates push the price back up.

What moves the price of XBIUSDT?

XBIUSDT price moves when XBI (the SPDR S&P Biotech ETF) moves, and XBI responds most sharply to FDA regulatory decisions (PDUFA dates and drug approvals), clinical trial data releases, macro interest rate expectations, and broad market risk-on/risk-off shifts. For today's specific catalyst driving movement, see the market drivers section above.

Is XBIUSDT available on Binance?

XBIUSDT is available on Bybit (primary venue) and MEXC as a USDT perpetual contract. As of this writing, XBIUSDT is not listed on Binance. Traders looking for the pair should access it directly through the Bybit XBIUSDT trading page.

What is the difference between XBI and IBB?

XBI uses an equal-weight methodology tracking the S&P Biotechnology Select Industry Index, giving small- and mid-cap biotech stocks the same index representation as large-cap names. IBB (iShares Biotechnology ETF, managed by BlackRock) is a cap-weighted fund tracking the NASDAQ Biotechnology Index (NBI), which also includes pharmaceutical companies and is dominated by large-cap holdings. XBI has historically shown higher volatility, and only XBI has a crypto perpetual contract (XBIUSDT). For a deeper comparison, see What Is XBIUSDT? Biotech ETF Trading Explained.

What is the funding rate on XBIUSDT?

The funding rate (the periodic payment exchanged between long and short holders every 8 hours on Bybit) is displayed in the live metrics dashboard at the top of this page. A positive rate means long positions pay short positions; a negative rate means shorts pay longs. For a full explanation of how to interpret the current rate as a sentiment signal, see the full funding rate explanation above.

What are the top holdings of XBI?

XBI holds approximately 130+ biotechnology companies with equal weighting, meaning no single stock dominates the fund. For the current top 10 holdings with percentage weights, see the XBI ETF breakdown above. Holdings data changes quarterly with rebalancing, so the table is sourced from SSGA.com and dated at each update.

How do I trade XBIUSDT?

To trade XBIUSDT, open a derivatives account on Bybit, complete identity verification, fund the account with USDT, navigate to the USDT Perpetual section, and search for the XBI pair. Select your leverage level before placing an order, and ensure your position size accounts for liquidation risk. For a detailed walkthrough, see the XBIUSDT perpetual trading guide.

Why is the biotech ETF price moving today?

XBI and XBIUSDT can move sharply on FDA regulatory decisions, clinical trial data releases, interest rate expectations, or broad market risk-on/risk-off shifts. The specific catalyst driving today's session is covered in the market drivers section above, including any active PDUFA dates or Phase 3 readouts from XBI holdings.

Related Reading

• What Is XBIUSDT? SPDR S&P Biotech ETF Explained
• What Is XBIUSDT? Biotech ETF Trading Explained for Beginners
• XBIUSDT Forecast 2026: Biotech ETF Price Targets
• How to Trade XBIUSDT Perpetual Contracts
• Open Interest Limit Perpetual Futures Contracts

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Trading perpetual futures involves significant risk, including the potential for total loss of margin capital. Past performance is not indicative of future results. Always conduct your own research before making financial decisions.